When we challenge, we advance. - Boston Scientific
ボストン・サイエンティフィックは、全従業員が「品質向上」を軸に患者ケアを支える企業文化を持っています。 2024年11月に東京で開催されたEMAIイベントでは、患者さんの人生を変えた治療事例を共有し、従業員が自身の仕事の意義を再確認する場となりました。 新たな試みとして、同僚間の交流を深めるアフタヌーンティー形式のセッションも実施。 イベントを通じて …
Global Locations - About Us - Boston Scientific
Boston Scientific operates corporate headquarters, customer fulfillment centers, manufacturing plants and educational facilities around the globe.
会社概要 - Boston Scientific
ボストン・サイエンティフィックは、患者さんへの負担を可能な限り軽くすることのできる低侵襲治療（インターベンション）に特化した医療機器メーカーとして、1979年に米国で誕生しました。 現在、取り扱う製品は17,000種以上。 グローバルで約41,000名の従業員、16ヵ所の製造拠点を擁し、115ヵ国近くのマーケットで確固たる地位を築いている世界最大級の医療機器 …
Boston Scientific receives Japanese regulatory approval for the ...
Sep 27, 2024 · Adding to its robust body of clinical evidence for the FARAPULSE PFA System, Boston Scientific expects to initiate the OPTION-A clinical trial in Japan, China, Taiwan and Hong Kong in early 2025 to study the safety and efficacy of concomitant procedures using the FARAPULSE PFA System for cardiac ablation and the WATCHMAN FLX™ Pro Left Atrial ...
【Japan】JapanClinical Science Liaison Position Job Details | Boston ...
The Japan field based “Clinical Science Liaison” (CSL) is responsible for assisting the Boston Scientific Interventional Oncology and Embolization (IO&E) clinical and medical department with clinical trial site activities including on-site investigator and personnel support.
Boston Scientific Receives Japanese Regulatory Approval for the ...
Sep 27, 2024 · Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System.
Boston Scientific's FARAPULSE Pulsed Field Ablation System Gets ...
Sep 27, 2024 · (RTTNews) - Boston Scientific Corp. (BSX) announced Friday that it has received Pharmaceuticals and Medical Device Agency approval in Japan for the FARAPULSE Pulsed Field Ablation or PFA...
Boston Scientific Earns Japanese Regulatory Approval for Pulsed …
Sep 27, 2024 · Boston Scientific announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE Pulsed Field Ablation (PFA) System.
Gaining a global perspective - Boston Scientific
Sep 15, 2021 · By Stephen Morse, president, Boston Scientific Japan. September 15, 2021. Relocating to Japan has been quite the experience. Despite growing up in a globally connected place like New York City, and traveling extensively for work, my four years living and working in Japan have challenged and energized me.
BSX Stock Gains From FARAPULSE PFA's PMDA Approval in Japan
Sep 30, 2024 · Boston Scientific expects to launch the FARAPULSE PFA System in Japan in the upcoming weeks to treat approximately 1 million people affected by AF. Subsequent to the announcement, shares of...